Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Rituximab Use in Pediatric Central Demyelinating Disease.
Quality of life and depression in multiple sclerosis patients: longitudinal results of the BetaPlus study.
Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study.
The mystery of missing heritability: Genetic interactions create phantom heritability.
Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude.
Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis.
Roche reports positive studies of MabThera given by subcutaneous injection
[Nicolau syndrome after administration of glatiramer acetate].
Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS.
Long-Term Safety and Efficacy Study of BIIB017 (PEGylated Interferon Beta-1a) (ATTAIN)
Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility.
Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.
Teva announces FDA acceptance of sNDA for a higher concentration dose of COPAXONE® given three times a week
Effectiveness of glatiramer acetate compared to other multiple sclerosis therapies.
Varicella-Zoster Virus Infections in Patients Treated With Fingolimod: Risk Assessment and Consensus Recommendations for Management.
Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis.
The potential role of epigenetic modifications in the heritability of multiple sclerosis.
Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.
Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench.
Company restores access to multiple sclerosis drug after pressure from neurologists.
Takeda Submits a New Drug Application for Glatiramer Acetate in Japan for the Relapse Prevention of Multiple Sclerosis
The risk of varicella zoster virus infection in multiple sclerosis patients treated with fingolimod.
Remyelination therapy goes to trial for multiple sclerosis
IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis.
The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service.

Pages